Denali Therapeutics Inc. DNLI Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s finance lease liabilities?
- Denali Therapeutics Inc. (DNLI) reported finance lease liabilities of $5.51M in Q1 2026.
- How has Denali Therapeutics Inc.'s finance lease liabilities changed year-over-year?
- Denali Therapeutics Inc.'s finance lease liabilities decreased by 1.6% year-over-year, from $5.6M to $5.51M.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.